Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP578047.RAlR6srmWkpcfvpPZgIZMGua-e89ssmwNRcgcQ16IlQ0Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP578047.RAlR6srmWkpcfvpPZgIZMGua-e89ssmwNRcgcQ16IlQ0Q130_assertion type Assertion NP578047.RAlR6srmWkpcfvpPZgIZMGua-e89ssmwNRcgcQ16IlQ0Q130_head.
- NP578047.RAlR6srmWkpcfvpPZgIZMGua-e89ssmwNRcgcQ16IlQ0Q130_assertion description "[Resultant N-terminal truncated IFN mimetics functioned intracellularly as antivirals as well as therapeutics against experimental allergic encephalomyelitis without the undesirable side effects that limit the therapeutic efficacy of IFN? in treatment of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578047.RAlR6srmWkpcfvpPZgIZMGua-e89ssmwNRcgcQ16IlQ0Q130_provenance.
- NP578047.RAlR6srmWkpcfvpPZgIZMGua-e89ssmwNRcgcQ16IlQ0Q130_assertion evidence source_evidence_literature NP578047.RAlR6srmWkpcfvpPZgIZMGua-e89ssmwNRcgcQ16IlQ0Q130_provenance.
- NP578047.RAlR6srmWkpcfvpPZgIZMGua-e89ssmwNRcgcQ16IlQ0Q130_assertion SIO_000772 23110939 NP578047.RAlR6srmWkpcfvpPZgIZMGua-e89ssmwNRcgcQ16IlQ0Q130_provenance.
- NP578047.RAlR6srmWkpcfvpPZgIZMGua-e89ssmwNRcgcQ16IlQ0Q130_assertion wasDerivedFrom befree-20140225 NP578047.RAlR6srmWkpcfvpPZgIZMGua-e89ssmwNRcgcQ16IlQ0Q130_provenance.
- NP578047.RAlR6srmWkpcfvpPZgIZMGua-e89ssmwNRcgcQ16IlQ0Q130_assertion wasGeneratedBy ECO_0000203 NP578047.RAlR6srmWkpcfvpPZgIZMGua-e89ssmwNRcgcQ16IlQ0Q130_provenance.